NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 14 11:53AM ET
13.48
Dollar change
+0.44
Percentage change
3.37
%
IndexRUT P/E- EPS (ttm)-2.20 Insider Own55.59% Shs Outstand33.42M Perf Week4.66%
Market Cap450.56M Forward P/E- EPS next Y-2.68 Insider Trans2.42% Shs Float14.84M Perf Month23.22%
Enterprise Value209.92M PEG- EPS next Q-0.75 Inst Own54.40% Short Float33.49% Perf Quarter114.99%
Income-73.47M P/S- EPS this Y52.89% Inst Trans21.67% Short Ratio16.59 Perf Half Y-7.10%
Sales0.00M P/B1.91 EPS next Y2.26% ROA-45.74% Short Interest4.97M Perf YTD-26.86%
Book/sh7.04 P/C1.87 EPS next 5Y16.53% ROE-48.22% 52W High27.50 -50.98% Perf Year-
Cash/sh7.20 P/FCF- EPS past 3/5Y-53.83% - ROIC-31.20% 52W Low4.81 180.43% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility9.12% 9.78% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)1.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio23.31 Sales Y/Y TTM- Profit Margin- RSI (14)62.88 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio23.31 EPS Q/Q-93.37% SMA2016.36% Beta- Target Price37.40
Payout- Debt/Eq0.00 Sales Q/Q- SMA5015.27% Rel Volume0.75 Prev Close13.04
Employees43 LT Debt/Eq0.00 EarningsMay 12 BMO SMA200-5.91% Avg Volume299.57K Price13.48
IPOSep 13, 2024 Option/ShortYes / Yes EPS/Sales Surpr.7.79% - Trades Volume89,130 Change3.37%
Date Action Analyst Rating Change Price Target Change
Apr-10-25Initiated Citizens JMP Mkt Outperform $38
Oct-08-24Initiated Stifel Buy $40
Oct-08-24Initiated JP Morgan Overweight $30
Oct-08-24Initiated Jefferies Buy $35
Oct-08-24Initiated Guggenheim Buy $44
Jun-23-25 08:00AM
Jun-16-25 08:00AM
Jun-10-25 08:00AM
May-20-25 08:00AM
May-15-25 07:16AM
07:00AM Loading…
May-13-25 07:00AM
May-12-25 08:00AM
May-08-25 07:00AM
May-05-25 07:00AM
Apr-22-25 08:00AM
Apr-07-25 08:00AM
Mar-26-25 08:00AM
Mar-17-25 08:00AM
Mar-05-25 08:00AM
Mar-03-25 08:00AM
08:00AM Loading…
Feb-18-25 08:00AM
Jan-23-25 08:00AM
Jan-07-25 11:47AM
07:00AM
Dec-18-24 08:00AM
Dec-02-24 08:00AM
Nov-18-24 08:00AM
Nov-07-24 08:00AM
Oct-28-24 08:00AM
Oct-14-24 06:45AM
Sep-30-24 08:00AM
Sep-23-24 07:05PM
Sep-18-24 03:19AM
Sep-16-24 04:05PM
Sep-12-24 07:11PM
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pescovitz Ora H.DirectorApr 08 '25Buy5.897,69345,31224,329Apr 10 08:39 AM
GORDON CARL LDirectorFeb 18 '25Buy10.84143,1701,551,9633,255,000Feb 19 05:56 PM
GORDON CARL LDirectorFeb 14 '25Buy9.8747,502468,7933,205,930Feb 19 05:56 PM
ORBIMED ADVISORS LLCDirectorFeb 18 '25Buy10.84143,1701,551,9633,255,000Feb 19 05:52 PM
ORBIMED ADVISORS LLCDirectorFeb 14 '25Buy9.8747,502468,7933,205,930Feb 19 05:52 PM
Hawryluk P. KentPresident & CEOFeb 04 '25Buy10.6950,000534,500448,277Feb 05 04:17 PM
Mathers Edward TDirectorSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:28 PM
BASKETT FOREST10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:26 PM
Behbahani Ali10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:24 PM
Chang Carmen10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:23 PM
Florence Anthony A. Jr.10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:21 PM
Makhzoumi Mohamad10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:20 PM
Walker Paul Edward10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:18 PM
Yang Rick10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:17 PM
SANDELL SCOTT D10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:14 PM
ORBIMED ADVISORS LLCDirectorSep 16 '24Buy16.00750,00012,000,0003,158,428Sep 17 08:13 PM
New Enterprise Associates 17, 10% OwnerSep 16 '24Buy16.00500,0008,000,0003,614,486Sep 17 08:12 PM
Frazier Life Sciences X, L.P.10% OwnerSep 16 '24Buy16.00625,00010,000,0004,552,774Sep 17 08:11 PM
Heron Patrick JDirectorSep 16 '24Buy16.00625,00010,000,0004,552,774Sep 17 08:09 PM
Aynechi TibaDirectorSep 16 '24Buy16.00750,00012,000,0002,136,335Sep 17 08:05 PM
GORDON CARL LDirectorSep 16 '24Buy16.00750,00012,000,0003,158,428Sep 17 08:05 PM